Clinical Trial Results TV
February 9, 2010: The JUPITER Trial: Rationale, Results, and Public Health Implications
Dr. Paul Ridker and Dr. C. Michael Gibson discuss the JUPITER Trial. Dr. Ridker presents
"hsCRP, Inflammation, LDL, and The JUPITER Trial: Rationale, Results, and Public
Health Implications."

Disclosures for Dr. Ridker at the time of filming:

Dr. Ridker has received investigator-initiated research support from the NHLBI, NCI,
American Heart Association, Donald W Reynolds Foundation, Leduc Foundation, Doris Duke
Charitable Foundation, AstraZeneca, Novartis, and SanofiAventis.
Dr. Ridker has served as a consultant to Seimens, AstraZeneca, Vascular Biogenics, Merck
Schering Plough, and Novartis.
Dr. Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital
that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes
that have been licensed to Seimens and AstraZeneca.

Disclosures for Dr. Gibson at the time of filming:

Present Research/Grant Funding

Abbott; Angel Medical Corporation; Astra Zeneca; Atrium Medical Systems; Baxter; Bayer
Corp. Cardica, Inc.; FibroGen, Inc.; Fold Rx; Genentech, Inc.; HeartScape Technologies;
INO Therapeutics, Inc.; Johnson & Johnson Corporation; Lantheus Medical Imaging;
NewCardio, Inc.; Portola Pharmaceuticals; Sanofi-Aventis; Schering Plough Corporation

Consultant and Speaking Engagements

Acusphere, Inc.; Angel Medical Systems; Archemix Corporation; Ascenta Therapeutics Atrium
Medical Corporation; Bayer Corporation; Cardica Inc.; Heartscape Technologies, Inc.; ICON
Medical Imaging; Jim Moran Heart and Vascular Research Institute; John & Johnson
Corporation; Medicure, Inc.; Novartis Pharmaceutical Corporation; Portola Pharmaceuticals,
Inc.; Sanofi-Aventis Pharmaceuticals; Schering Plough Corporation; St. Jude Medical; The
Medicines Company

Royalties as a Contributor

UpToDate in Cardiovascular Medicine; Pocket Medicine

Past Research/Grant Funding/Past Speakers Bureau/Past Consulting

ActivBiotics, Inc.; Acusphere, Inc.; Ascenta Therapeutics, Inc; Astra; Atrium Medical
Corporation; Bard Corporation; Biogen IDEC; Boston Scientific Corporation; Bristol Meyers
Squibb Company; British Biotech, plc.; CardioKinetix, Inc.; Ciba Geigy Corporation; COR
Therapeutics; Corgentech, Inc.; DVI Guidant Corporation; Eli Lilly and Company; Genentech,
Inc.; GlaxoSmithKline; INO Therapeutics, LLC; KAI Pharmaceuticals; Merck & Co., Inc.;
Millennium Pharmaceuticals; Momenta Pharmaceuticals; NIH; Novartis Corporation; Nuvelo;
PDL Pharmaceuticals; Percusurge, Inc.; Pfizer; Point Biomedical Corporation; Portola
Pharmaceuticals, Inc.; Sanofi-Aventis Corporation; Smith Kline Beecham; Sonus; St. Jude
Medical; The Medicines Company; timi3 Systems, Inc.

[ Download video ]

Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
09-20-2019 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted